Pancreatic Cancer Research

ResearcherUniversity of Rome Tor VergataActive in the last 2 years

Vittore Cereda

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-3717-0655; OpenAlex author ID A5004112514. Sources: OpenAlex.

Their work

Papers
2
Trials
0
Grants
0
Labs led
0
Collaborators
4
Papers, trials and grants by year

2016: 1 paper · 2017: none · 2018: none · 2019: none · 2020: none · 2021: none · 2022: none · 2023: none · 2024: none · 2025: 1 paper

Papers 2

  1. Pancreatic cancer: failures and hopes-a review of new promising treatment approaches. Co-author DOI 10.37349/etat.2025.1002299↗
  2. Neutrophil/lymphocyte ratio helps select metastatic pancreatic cancer patients benefitting from oxaliplatin. Co-author DOI 10.3233/cbm-160645↗

Closest collaborators

The 4 strongest of 4 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Mario Rosario D'Andrea · 1 shared paper, 2025 · strength 0.54
  2. Mario Roselli · 1 shared paper, 2016 · strength 0.05
  3. Vincenzo Formica · 1 shared paper, 2016 · strength 0.05
  4. Antonio Dello Russo · 1 shared paper, 2016 · strength 0.05

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.